
Seokheun “Sean” Choi, an associate professor of electrical and computer engineering, has developed a new device for faster testing of antibiotic-resistant bacteria.
Bacterial infections have become one of the biggest health problems worldwide, and a recent study shows that COVID-19 patients have a much greater chance of acquiring secondary bacterial infections, which significantly increases the mortality rate.
Combatting the infections is no easy task, though. When antibiotics are carelessly and excessively prescribed, that leads to the rapid emergence and spread of antibiotic-resistant genes in bacteria — creating an even larger problem. According to the Centers for Disease Control and Prevention, 2.8 million antibiotic-resistant infections happen in the U.S. each year, and more than 35,000 people die from of them.
One factor slowing down the fight against antibiotic-resistant bacteria is the amount of time needed to test for it. The conventional method uses extracted bacteria from a patient and compares lab cultures grown with and without antibiotics, but results can take one to two days, increasing the mortality rate, the length of hospital stay and overall cost of care.
Associate Professor Seokheun “Sean” Choi — a faculty member in the Department of Electrical and Computer Engineering at Binghamton University’s Thomas J. Watson College of Engineering and Applied Science — is researching a faster way to test bacteria for antibiotic resistance.
“To effectively treat the infections, we need to select the right antibiotics with the exact dose for the appropriate duration,” he said. “There’s a need to develop an antibiotic-susceptibility testing method and offer effective guidelines to treat these infections.”
In the past few years, Choi has developed several projects that cross “papertronics” with biology, such as one that developed biobatteries using human sweat.
This new research — titled “A simple, inexpensive, and rapid method to assess antibiotic effectiveness against exoelectrogenic bacteria” and published in November’s issue of the journal Biosensors and Bioelectronics — relies on the same principles as the batteries: Bacterial electron transfer, a chemical process that certain microorganisms use for growth, overall cell maintenance and information exchange with surrounding microorganisms.
“We leverage this biochemical event for a new technique to assess the antibiotic effectiveness against bacteria without monitoring the whole bacterial growth,” Choi said. “As far as I know, we are the first to demonstrate this technique in a rapid and high-throughput manner by using paper as a substrate.”
Working with PhD students Yang Gao (who earned his degree in May and is now working as a postdoctoral researcher at the University of Texas at Austin), Jihyun Ryu and Lin Liu, Choi developed a testing device that continuously monitors bacteria’s extracellular electron transfer.
A medical team would extract a sample from a patient, inoculate the bacteria with various antibiotics over a few hours and then measure the electron transfer rate. A lower rate would mean that the antibiotics are working.
“The hypothesis is that the antiviral exposure could cause sufficient inhibition to the bacterial electron transfer, so the readout by the device would be sensitive enough to show small variations in the electrical output caused by changes in antibiotic effectiveness,” Choi said.
The device could provide results about antibiotic resistance in just five hours, which would serve as an important point-of-care diagnostic tool, especially in areas with limited resources.
The prototype — built in part with funding from the National Science Foundation and the U.S. Office of Naval Research — has eight sensors printed on its paper surface, but that could be extended to 64 or 96 sensors if medical professionals wanted to build other tests into the device.
Building on this research, Choi already knows where he and his students would like to go next: “Although many bacteria are energy-producing, some pathogens do not perform extracellular electron transfer and may not be used directly in our platform. However, various chemical compounds can assist the electron transfer from non-electricity-producing bacteria.
“For instance, E. coli cannot transfer electrons from the inside of the cell to the outside, but with the addition of some chemical compounds, they can generate electricity. Now we are working on how to make this technique general to all bacteria cells.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Bacterial infections
- Community Acquired Bacterial Pneumonia Treatment Market to Hit US$ 2672.1 million by 2030: Growth Plus Reports
A new antibody, CMTX-101 is created for treating serious bacterial infections. It quickly eliminates the bacterial biofilms' universal underlying structure to subsequently weaken extracellular ...
- Death toll rises from bacterial infection linked to recalled eye drops
The bacteria has now been detected in 16 states ... who have used any of the recalled products and subsequently experience signs or symptoms of an eye infection should seek medical attention ...
- Two additional deaths linked to bacteria in recalled eye drops, CDC says
A rare strain of bacteria found in recalled eye drops has been linked to dozens of infections, as well as cases of vision loss and surgical removal of eyes. This week, the U.S. Centers for Disease ...
- Deaths, Blindness Linked to Recalled Eye Drops Contaminated with Antibiotic-Resistant Bacteria
The CDC reports that along with the death of three individuals, eight individuals have gone blind, and four additional individuals have needed the surgical removal of an eyeball after using ...
- Multiple Drug Resistance Bacterial Infection Treatment Market New Report 2023 to 2031
Multiple Drug Resistance Bacterial Infection Treatment Market” Understandings Are A Collection Of Information and ...
Go deeper with Google Headlines on:
Bacterial infections
[google_news title=”” keyword=”lithium” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Antibiotic-resistant bacteria
- Fomepizole helps overcome antibiotic-resistant pneumonia in mice, study finds
Pneumococcal disease leads to over three million hospitalizations and hundreds of thousands of deaths annually. A new study suggests that the FDA-approved drug Fomepizole may reduce disease severity ...
- Deaths, Blindness Linked to Recalled Eye Drops Contaminated with Antibiotic-Resistant Bacteria
Along with the death of three individuals, eight individuals have gone blind, and four additional individuals have needed to surgically remove an eyeball after using contaminated eye drops, the CDC sa ...
- Mass. doctor on drug-resistant bacteria in eye drop bottles
Two more deaths are now linked to rare strain of drug-resistant bacteria discovered recently in bottles of eye drops.
- 2 more deaths linked to recalled eyedrops with drug-resistant bacteria
The eyedrops from EzriCare and Delsam Phama were recalled in February and health authorities are continuing to track infections as they investigate the outbreak.
- A deadly drug-resistant bacteria is linked to recalled eye drops. Here is what to know.
Three people have died, eight lost their vision, and four had an eyeball removed surgically due to a drug-resistant strain of Pseudomonas aeruginosa.
Go deeper with Google Headlines on:
Antibiotic-resistant bacteria
[google_news title=”” keyword=”antibiotic-resistant bacteria” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]